021-51111890
购物车（0）
sales@molnova.cn
Dersalazine
CAS No. 188913-58-8
Dersalazine ( —— )
产品货号. M36326 CAS No. 188913-58-8
Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥2713 | 有现货 |
|
| 5MG | ￥4199 | 有现货 |
|
| 10MG | ￥6080 | 有现货 |
|
| 25MG | ￥9071 | 有现货 |
|
| 50MG | ￥12277 | 有现货 |
|
| 100MG | ￥16218 | 有现货 |
|
| 500MG | ￥32513 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Dersalazine
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.
-
产品描述Dersalazine (Dersalazine Free Base), an inhibitor of platelet-activating factor, exerts intestinal anti-inflammatory activity in different rodent types of colitis by down-regulating IL-17 expression, with potential efficacy in patients with ulcerative colitis.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Apoptosis
-
靶点IL Receptor
-
受体IL Receptor | Platelet aggregation
-
研究领域——
-
适应症——
化学信息
-
CAS Number188913-58-8
-
分子量600.67
-
分子式C35H32N6O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(N1C=2C(N=C1C)=CN=CC2)C3CCN(C(/C=C(\C4=CC=C(N=NC5=CC(C(O)=O)=C(O)C=C5)C=C4)/C6=CC=CC=C6)=O)CC3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Kansuinine A
Kansuinine A 是一种从 E. kansui 根中提取的 95% 乙醇提取物，通过激活 ERK1/2 对 IL-6 诱导的 Stat3 激活具有抑制作用。
-
Aristololactam I
Aristololactam I 具有细胞毒性效力，通过在 caspase 3 依赖性途径中诱导细胞凋亡来介导。
-
ABzOH
ABzOH is a benzoic acid derivative, similar in structure to non-steroidal anti-inflammatory drugs such as aspirin, with anti-inflammatory, anti-tumor and anti-proliferative effects. ABzOH can not only inhibit the expression of tumor necrosis factor-α (TNF-a), interleukin-1β (IL-1β), interleukin-6 (IL-6) and other pro-inflammatory cytokines, but also inhibit breast cancer, lung cancer and pancreatic cancer.
